Wave Life Sciences WVE Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's financing cash flow?
- Wave Life Sciences (WVE) reported financing cash flow of $2.53M in Q1 2026.
- How has Wave Life Sciences's financing cash flow changed year-over-year?
- Wave Life Sciences's financing cash flow decreased by 39.2% year-over-year, from $4.16M to $2.53M.
- What is the long-term trend for Wave Life Sciences's financing cash flow?
- Over 4 years (2021 to 2025), Wave Life Sciences's financing cash flow has grown at a 72.0% compound annual growth rate (CAGR), from $55.83M to $488.24M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.